Page 5 - Nasdaq Stro News Today

Sutro Biopharma (NASDAQ:STRO – Get Rating)‘s stock had its “buy” rating reaffirmed by equities researchers at JMP Securities in a research report issued to clients and investors on Monday, TipRanks reports. They presently have a $20.00 price objective on the stock. JMP Securities’ price objective points to a potential upside of 154.45% from the company’s […]

Analysts expect Sutro Biopharma, Inc. (NASDAQ:STRO – Get Rating) to report earnings of ($0.78) per share for the current fiscal quarter, Zacks reports. Five analysts have made estimates for Sutro Biopharma’s earnings, with the highest EPS estimate coming in at ($0.52) and the lowest estimate coming in at ($0.95). Sutro Biopharma posted earnings per share […]